Jamie Platt
Director/Board Member at BIOAFFINITY TECHNOLOGIES, INC.
Net worth: 30 530 $ as of 30/04/2024
Profile
Jamie Platt is currently the Chief Executive Officer & Director at Pictor Ltd.
She is also a Director at Dxterity Diagnostics, Inc. and an Independent Director at bioAffinity Technologies, Inc. In the past, she was a Director at Mobility Health, Inc. and the Chief Operating Officer at Personal Genome Diagnostics, Inc. and Inivata Ltd.
Dr. Platt holds a doctorate degree from Oregon State University and the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/04/2024 | 12,668 ( 0.11% ) | 30 530 $ | 30/04/2024 |
Jamie Platt active positions
| Companies | Position | Start |
|---|---|---|
| BIOAFFINITY TECHNOLOGIES, INC. | Director/Board Member | 01/12/2023 |
Pictor Ltd.
 Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Chief Executive Officer | - |
Dxterity Diagnostics, Inc.
 Dxterity Diagnostics, Inc. Medical/Nursing ServicesHealth Services Dxterity Diagnostics, Inc. develops simple and affordable genomic testing solutions for the research, diagnostic, and therapeutic markets. It offers direct to patient platform, digital recruitment, genomic services, and QSR product development. The company was founded by Robert Terbrueggen and Jim Healy in 2006 and is headquartered in Rancho Dominguez, CA. | Director/Board Member | 01/03/2021 |
Former positions of Jamie Platt
| Companies | Position | End |
|---|---|---|
Personal Genome Diagnostics, Inc.
 Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Chief Operating Officer | 01/04/2023 |
Inivata Ltd.
 Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Chief Operating Officer | 01/01/2021 |
| Mobility Health, Inc. | Director/Board Member | - |
Training of Jamie Platt
| Oregon State University | Doctorate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Dxterity Diagnostics, Inc.
Dxterity Diagnostics, Inc. Medical/Nursing ServicesHealth Services Dxterity Diagnostics, Inc. develops simple and affordable genomic testing solutions for the research, diagnostic, and therapeutic markets. It offers direct to patient platform, digital recruitment, genomic services, and QSR product development. The company was founded by Robert Terbrueggen and Jim Healy in 2006 and is headquartered in Rancho Dominguez, CA. | Health Services |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Health Technology |
Pictor Ltd.
Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Health Technology |
| bioAffinity Technologies, Inc. | |
| Mobility Health, Inc. | |
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Stock Market
- Insiders
- Jamie Platt
